217 results
Page 6 of 11
424B5
ah1d7qucns
28 Apr 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
q6pa7
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am
8-K
EX-99.1
91g6qyh3e0 rb3rb5
26 Feb 10
Discovery Labs Announces Completion of
12:00am
424B5
x4oe59tg
19 Feb 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
637rto1ljxqirto
18 Feb 10
Discovery Labs Prices $16.5 Million Public Offering of
12:00am
424B5
8t18yimk
17 Feb 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
s7y9kbtlrroijrws ql1
4 Dec 09
Discovery Labs Receives Nasdaq Notification Related
12:00am
8-K
EX-99.2
fpaoak
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
EX-99.1
m7hk3n 3eq120t1t
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
EX-99.1
ny0 qbppjo07
30 Sep 09
Discovery Labs and FDA Establish Path for Potential SURFAXIN Approval
12:00am
8-K
EX-99.1
ijtmb2eyn2wmto
11 Sep 09
Other Events
12:00am
8-K
EX-99.1
s0n8 4rq2zcuc2cpnv
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
EX-10.1
bzz vo4zxdxga4sieei7
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
EX-99.1
i2xx yt28
19 Aug 09
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
12:00am
8-K
EX-99.1
kgn tkge9cyh7ase7nz6
3 Aug 09
Discovery Labs Provides Second Quarter 2009 Financial Results and Business Strategy Update
12:00am